Rat angiotensin-converting enzyme promoter regulation by β-adrenergics and cAMP in endothelium

被引:21
|
作者
Xavier-Neto, J
Pereira, AC
Junqueira, MD
Carmona, R
Krieger, JE
机构
[1] Univ Sao Paulo, Fac Med, Inst Coracao, Lab Genet & Cardiol Mol, BR-05403000 Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med, Inst Coracao, Dept Clin Med,LIM 13, BR-05403000 Sao Paulo, Brazil
关键词
angiotensin-converting enzyme; endothelium; receptors; adrenergic; beta; cyclic AMP; luciferase;
D O I
10.1161/01.HYP.34.1.31
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To shed light on mechanisms of angiotensin-converting enzyme (ACE) upregulation, we used a rabbit endothelial cell model to characterize intracellular pathways of beta-adrenergic stimulation. In these cells, ACE activity is increased by isoproterenol (ISO). The stably transfected 1273-bp ACE promoter is stimulated by ISO in the presence of isobutyl methylxanthine. This effect is abolished by propranolol. Promoter stimulation is mimicked by cholera toxin, forskolin, and 8BrcAMP, but not by 8BrcGMP. Promoter stimulation by ISO and isobutyl methylxanthine is blocked by protein kinase A inhibitors, indicating that beta-adrenergic stimulation of the ACE gene depends on phosphorylation of protein kinase A targets. Activation by cAMP, resistance to phorbol ester, and lack of synergism between cAMP and phorbol ester suggest that promoter regulation is due to cAMP responsive element rather than to activating protein-2 sequences. Okadaic acid potentiation of 8BrcAMP induction indicated that promoter activation by cAMP is regulated by phosphatases controlling activation of typical cAMP responsive element regulated genes. In summary, beta-adrenergic activation of rat ACE promoter is specific; uses G(s) proteins, adenylyl cyclase, protein kinase A; and probably includes cAMP responsive element-like sequences.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [1] Estrogen regulation of angiotensin-converting enzyme mRNA
    Gallagher, PE
    Li, P
    Lenhart, JR
    Chappell, MC
    Brosnihan, KB
    HYPERTENSION, 1999, 33 (01) : 323 - 328
  • [2] Endothelium-dependent responses and inhibition of angiotensin-converting enzyme
    Vanhoutte, PM
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (08) : S23 - S29
  • [3] Endothelium-dependent responses and inhibition of angiotensin-converting enzyme
    Vanhoutte, PM
    KARDIOLOGIYA, 1996, 36 (11) : 71 - 79
  • [4] Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor
    d'Alessandro, Miriana
    Bergantini, Laura
    Perrone, Anna
    Cameli, Paolo
    Cameli, Matteo
    Prasse, Antje
    Plataroti, Dario
    Sestini, Piersante
    Bargagli, Elena
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 78 : 58 - 62
  • [5] Conversion of Aβ43 to Aβ40 by the Successive Action of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme
    Liu, Shuyu
    Liu, Junjun
    Miura, Yukie
    Tanabe, Chiaki
    Maeda, Tomoji
    Terayama, Yasuo
    Turner, Anthony J.
    Zou, Kun
    Komano, Hiroto
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (09) : 1178 - 1186
  • [6] Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans
    Orfanos, SE
    Langleben, D
    Khoury, J
    Schlesinger, RD
    Dragatakis, L
    Roussos, C
    Ryan, JW
    Catravas, JD
    CIRCULATION, 1999, 99 (12) : 1593 - 1599
  • [7] Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
    Ferrario, CM
    Jessup, J
    Chappell, MC
    Averill, DB
    Brosnihan, KB
    Tallant, EA
    Diz, DI
    Gallagher, PE
    CIRCULATION, 2005, 111 (20) : 2605 - 2610
  • [8] Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
    Meurs, Kathryn M.
    Stern, Joshua A.
    Atkins, Clarke E.
    Adin, Darcy
    Aona, Brent
    Condit, Julia
    DeFrancesco, Teresa
    Reina-Doreste, Yamir
    Keene, Bruce W.
    Tou, Sandy
    Ward, Jessica
    Woodruff, Kathleen
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2017, 18 (04) : 1 - 4
  • [9] Factors regulating renal angiotensin-converting enzyme activity in the rat
    Ye, VZC
    Duggan, KA
    ACTA PHYSIOLOGICA SCANDINAVICA, 2000, 169 (01): : 21 - 27
  • [10] Angiotensin-converting enzyme 2 and angiotensin-(1-7) - An evolving story in cardiovascular regulation
    Ferrario, CM
    HYPERTENSION, 2006, 47 (03) : 515 - 521